Retrovirus-like particles from the human T47D cell line are related to mouse mammary tumour virus and are of human endogenous origin Free

Abstract

Retrovirus-like particles were secreted in a steroid-dependent manner by the human mammary carcinoma cell line T47D. The particles exhibited typical retroviral properties such as their electron microscopic appearance (95 nm in diameter) and occasional budding, sedimentation at 1.14 g/ml, reverse transcriptase activity and genomic RNA. The T47D particles were related to mouse mammary tumour virus (MMTV) as shown by their ultrastructural appearance (B type-like eccentric dense cores and budding), Mg dependence of the reverse transcriptase activity; immunological reactivity with MMTV-directed antibodies (revealing proteins of 63K, 52K, 26K and 18K), and hybridization of particle RNA with MMTV DNA under stringent conditions. Purified particles were able to incorporate deoxynucleoside triphosphates in the absence of an exogenous primer and template, thus indicating the existence of a complete and biochemically functional reverse transcription apparatus (reverse transcriptase, RNA and primer) and the ability to direct endogenous cDNA synthesis. Labelled particle cDNA hybridized strongly to human genomic DNA but not to mouse and cat DNA, thus indicating the human origin of the T47D particles. Furthermore all human DNAs, hybridized with the labelled particle cDNA, showed a uniform hybridization pattern of restriction fragments, indicating the endogenous origin and distribution of the proviral particle DNA in the human genome.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-73-5-1087
1992-05-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/73/5/JV0730051087.html?itemId=/content/journal/jgv/10.1099/0022-1317-73-5-1087&mimeType=html&fmt=ahah

References

  1. Acha-Orbea H., Palmer E. 1991; Mls – a retrovirus exploits the immune system. Immunology Today 12:3563–61
    [Google Scholar]
  2. Acha-Orbea H., Shakhov A. N., Scarpellino L., Kolb E., Muller V., Vessaz-Shaw A., Fuchs R., Blochlinger K., Rollini P., Billotte J., Sarafidou M., MacDonald H. R., Diggelmann H. 1991; Clonal deletion of Vβ 14-bearing T cells in mice transgenic for mammary tumour virus. Nature, London 350:207–211
    [Google Scholar]
  3. Al-Sumidaie A. M., Hart C. A., Leinster S. J., Green C. D., McCarthy K. 1988; Particles with properties of retroviruses in monocytes from patients with breast cancer. Lancet ii:5–9
    [Google Scholar]
  4. Axel R., Schlom J., Spiegel man S. 1972a; Presence in human breast cancer of RNA homologous to mouse mammary tumour virus RNA. Nature, London 235:32–36
    [Google Scholar]
  5. Axel R., Gulati S. C., Spiegelman S. 1972b; Particles containing RNA-instructed DNA polymerase and virus-related RNA in human breast cancers. Proceedings of the National Academy of Sciences, U.S.A. 69:3133–3137
    [Google Scholar]
  6. Beard J. W. 1963; Avian virus growth and their etiologic agents. Advances in Cancer Research 7:1–127
    [Google Scholar]
  7. Bishop M. J. 1987; The molecular genetics of cancer. Science 235:305–311
    [Google Scholar]
  8. Callahan R. 1988; Two families of human endogenous retroviral genomes. In Eukaryotic Transposable Elements as Mutagenic Agents: Banbury Report 30 pp 91–100 Edited by Lambert M. E., McDonald I. F., Weinstein I. B. New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  9. Callahan R., Drohan W., Tronick S., Schlom J. 1982; Detection and cloning of human DNA sequences related to the mouse mammary tumor virus genome. Proceedings of the National Academy of Sciences, U.S.A. 79:5503–5507
    [Google Scholar]
  10. Choi Y., Kappler J. W., Marrack P. 1991; A superantigen encoded in the open reading frame of the 3′ long terminal repeat of mouse mammary tumour virus. Nature, London 350:203–207
    [Google Scholar]
  11. Deen K. C., Sweet R. W. 1986; Murine mammary tumor virus pol-related sequence in human DNA: characterization and sequence comparison with the complete murine mammary tumor virus pol gene. Journal of Virology 57:422–432
    [Google Scholar]
  12. Dickson C., Atterwill M. 1978; Polyproteins related to the major core protein of mouse mammary tumor virus. Journal of Virology 26:660–672
    [Google Scholar]
  13. Dyson P. J., Knight A. M., Fairchild S., Simpson E., Tomonari K. 1991; Genes encoding ligands for deletion of Vβ 11 T cells cosegregate with mammary tumour virus genomes. Nature, London 349:531–532
    [Google Scholar]
  14. Faff O., Erfle V., Hehlmann R. 1989; Microassay of reverse transcriptase in microtitre plates. Methods in Molecular and Cellular Biology 2:67–72
    [Google Scholar]
  15. Frankel W. N., Rudy C., Coffin J. M., Huber B. T. 1991; Linkage of Mis genes to endogenous mammary tumour viruses of inbred mice. Nature, London 349:526–528
    [Google Scholar]
  16. Franklin G. C., Chretien S., Hanson I. M., Rochefort H., Bay F. E. B., Westly R. 1988; Expression of human sequences related to those of mouse mammary tumor virus. Journal of Virology 62:1203–1210
    [Google Scholar]
  17. Gössner W., Hehlmann R., Schreiber M. S., Lohe K. J., Prechtel F. 1985; Immunohistochemical studies with retrovirusspecific antibodies in benign and malignant breast lesions. Verhandlungen der Deutschen Gesellschaft für Pathologie 69:249–253
    [Google Scholar]
  18. Gross L. 1983 Oncogenic Tumor Viruses 3rd edition London: Pergamon Press;
    [Google Scholar]
  19. Günzburg W. H., Salmons B. 1986; Mouse mammary tumor virus mediated transfer and expression of neomycin resistance to infected cultured cells. Virology 155:236–248
    [Google Scholar]
  20. Hehlmann R. 1976; RNA tumor viruses and human cancer. Current Topics in Microbiology and Immunology 73:141–215
    [Google Scholar]
  21. Hehlmann R., Baumgarten A., Schreiber M. A., Schetters H., Luz A., Mesa-Tejada R., Lohe K. J., Prechtel K. 1981; Kreuzreaktion menschlicher Mammakarzinome mit dem Hullglyco-protein gp52 des Mausmamma-tumorvirus (MMTV). Verhandlungen der Deutschen Gesellschaft für Pathologie 65:275–279
    [Google Scholar]
  22. Hehlmann R., Schreiber M. S., Kreeb G., Luz A., Mesa-Tejada R., Lohe K. J., Prechtel K. 1983; Kreuzreaktionen menschlicher Mammakarzinome mit Mammatumorvirusantigenen und mögliche diagnostische Bedeutung. Verhandlungen der Deutschen Gesellschaft für Innere Medizin 89:1025–1029
    [Google Scholar]
  23. Hügin A. W., Vacchio M. S., Morse H. C. III 1991; A virus-encoded “superantigen” in a retrovirus-induced immunodeficiency syndrome of mice. Science 252:424–427
    [Google Scholar]
  24. Imberati L., Sottini A., Bettinardi A., Puoti M., Primi D. 1991; Selective depletion in HIV infection of T cells that bear specific T cell receptor Vβ sequences. Science 254:860–862
    [Google Scholar]
  25. Kahl L. P., Carroll A. R., Rhodes P., Wood J., Reod N. G. 1991; An evaluation of the putative human mammary tumour retrovirus associated with peripheral blood monocytes. British Journal of Cancer 63:534–540
    [Google Scholar]
  26. Keydar I., Chen L., Karby S., Weiss F. R., Delarea J., Radu M., Chaitchick S., Brenner H. J. 1979; Establishment and characterization of a cell line of human breast carcinoma origin. European Journal of Cancer 15:659–670
    [Google Scholar]
  27. Keydar I., Selzer G., Chaitchik S., Hareuveni M., Karby S., Hizi A. 1982; A viral antigen as a marker for the prognosis of human breast cancer. European Journal of Cancer and Clinical Oncology 18:1321–1328
    [Google Scholar]
  28. Keydar I., Ohno T., Nayak R., Sweet R., Simoni F., Weiss F., Karby S., Mesa-Tejada R., Spiegelman S. 1984; Properties of retrovirus-like particles produced by a human breast carcinoma cell line: immunological relationship with mouse mammary tumor virus proteins. Proceedings of the National Academy of Sciences, U.S.A. 81:4188–4192
    [Google Scholar]
  29. Keydar I., Tsarfaty J., Smorodinsky N., Sahar E., Shoenfeld Y., Chaitchik S. 1986; Human monoclonal antibodies directed against HuMTV antigens from human breast cancer cells. In New Experimental Modalities in the Control of Neoplasia pp 123–135 Edited by Chandra P. Nato Advanced Study Institute 1985 New York: Plenum Press;
    [Google Scholar]
  30. Kyse-Anderson J. 1984; Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. Journal of Biochemical and Biophysical Methods 10:203–209
    [Google Scholar]
  31. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, London 227:680–685
    [Google Scholar]
  32. McGrath C. M., Grant P. H., Sonle H. D., Glancy T., Rich M. A. 1972; Replication of oncornavirus-like particle in human breast carcinoma cell line, MCF-7. Nature, London 252:247–250
    [Google Scholar]
  33. Maniatis T., Fritsch E. F., Sambrook J. 1982 Molecular Cloning: A Laboratory Manual New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  34. Marrack P., Kushnir E., Kappler J. 1991; A maternally inherited superantigen encoded by a mammary tumor virus. Nature, London 349:524–526
    [Google Scholar]
  35. May F. E., Westley B. R. 1986; Structure of a human retroviral sequence related to mouse mammary tumor virus. Journal of Virology 60:743–749
    [Google Scholar]
  36. May F. E., Westley B. R. 1989; Characterization of sequences related to the mouse mammary tumor virus that are specific to MCF-7 breast cancer cells. Cancer Research 49:3879–3883
    [Google Scholar]
  37. May F. E., Westley B. R., Rochefort H. 1983; Mouse mammary tumour virus related sequences are present in human DNA. Nucleic Acids Research 11:4127–4139
    [Google Scholar]
  38. Mesa-Tejada R., Keydar I., Ramanarayanan M., Ohno T., Fenoglio C., Spiegelman S. 1978; Detection in human breast carcinomas of an antigen immunologically related to a group specific antigen of mouse mammary tumor virus. Proceedings of the National Academy of Sciences, U.S.A. 75:1529–1533
    [Google Scholar]
  39. Mesa-Tejada R., Oster M. W., Fenoglio C. M., Magidson J., Spiegelman S. 1982; Diagnosis of primary breast carcinoma through immuno-histochemical detection of mouse mammary tumor virus-related antigen in metastatic lesions. A report of two cases. Cancer 49:261–268
    [Google Scholar]
  40. Michalides R., Spiegelman S., Schlom J. 1975; Biochemical characterisation of putative subviral particulates from malignant breast tumors. Cancer Research 35:1003–1008
    [Google Scholar]
  41. Michalides R., van Ooyen A., Nusse R. 1983; Mouse mammary tumor virus expression and mammary tumor development. Current Topics in Microbiology and Immunology 106:57–78
    [Google Scholar]
  42. Moore D., Long C. A., Vaidya A. A., Sheffield J. B., Dion A. S., LasFaRGUES E. J. 1979; Mammary tumor viruses. Advances in Cancer Research 29:347–418
    [Google Scholar]
  43. Moore D. H., Charney J., Kramarsky B., Lasfargues E. Y., Sarkar N. H., Brennan M. J., Burrows J. H., Sirsat S. M., Paymaster J. C., Vaidya A. B. 1971; Search for a human breast cancer virus. Nature, London 229:611–614
    [Google Scholar]
  44. O’Hehir R. E., Lamb J. R. 1990; Induction of specific clonal anergy in human T lymphocytes by Staphylococcus aureus enterotoxins. Proceedings of the National Academy of Sciences, U.S.A. 87:8884–8888
    [Google Scholar]
  45. Ohno T., Sweet R. W., Hu R., Dejyk D., Spiegelman S. 1977; Purification and characterisation of the DNA polymerase of human breast cancer particles. Proceedings of the National Academy of Sciences, U.S.A. 14:764–768
    [Google Scholar]
  46. Ono K. 1989; Mechanisms of antiretroviral compounds in inhibition of viral and cellular DNA polymerase. In Perspectives in Antiinfective Therapy pp 51–59 Edited by Jackson G. G., Schlumberger H. D., Zeiler H. J. Friedr. Vieweg & Sohn;
    [Google Scholar]
  47. Ono M., Yasunaga T., Miyata T., Ushikubo H. 1986; Nucleotide sequence of human endogenous retrovirus genome related to the mouse mammary tumor virus genome. Journal of Virology 60:589–598
    [Google Scholar]
  48. Ono M., Kavakami M., Ushikubo H. 1987; Stimulation of expression of the human endogenous retrovirus genome by female steroid hormones in human breast cancer cell line T47D. Journal of Virology 61:2059–2062
    [Google Scholar]
  49. Paertakul U., de Stasio P. R., Taylor M. W. 1988; A fast and sensitive method for detecting specific viral RNA in mammalian cells. Journal of Virology 62:1132–1135
    [Google Scholar]
  50. Poiesz B. J., Ruscetti F. W., Gazdar A. F., Bunn P. A., Minna J. D., Gallo R. C. 1980; Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proceedings of the National Academy of Sciences, U.S.A. 77:7415–7419
    [Google Scholar]
  51. Ponta H., Kennedy N., Herrlich P., Hynes N. E., Groner B. 1983; A deletion mutant of mouse mammary tumour virus, lacking 516 nucleotides of the 5′ long terminal repeat sequence, can be expressed in a hormone-responsive fashion. Journal of General Virology 64:567–577
    [Google Scholar]
  52. Redinbaugh M. G., Turley R. B. 1986; Adaptation of the bicinchoninic acid protein assay for use with microtiter plates and sucrose gradient fractions. Analytical Biochemistry 153:267–271
    [Google Scholar]
  53. Segev N., Hizi A., Kirenberg F., Keydar I. 1985; Characterization of a protein, released by the T47D cell line, immunologically related to the major envelope protein of mouse mammary tumor virus. Proceedings of the National Academy of Sciences, U.S.A. 82:1531–1535
    [Google Scholar]
  54. Smith P. K., Krohn R. J., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J., Klenk D. C. 1985; Measurement of protein using bicinchoninic acid. Analytical Biochemistry 150:76–85
    [Google Scholar]
  55. Southern E. M. 1975; Detection of specific sequences among DNA fragments separated by gel electrophoresis. Journal of Molecular Biology 98:503–517
    [Google Scholar]
  56. Vaidya A. B. 1973; Molecular biology of human milk. Science 180:776–779
    [Google Scholar]
  57. Vaidya A. B., Black M. M., Dion A. S., Moore D. H. 1974; Homology between human breast tumour RNA and mouse mammary tumour virus genome. Nature, London 249:565–567
    [Google Scholar]
  58. Varmus H. E. 1984; The molecular genetics of cellular oncogenesis. Annual Review of Genetics 18:553–612
    [Google Scholar]
  59. Varmus H. E. 1988; Retroviruses. Science 240:1427–1435
    [Google Scholar]
  60. Weiss R. 1984; The search for human RNA tumor viruses. In RNA Tumor Viruses pp 1205–1281 Edited by Weiss R., Teich N., Varmus H., Coffin J. New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  61. Weiss R., Teich N., Varmus H., Coffin J. (editors) 1982 RNA Tumor Viruses New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  62. Wong-Staal R., Gallo R. C. 1985; Human T-lymphotropic retroviruses. Nature, London 317:395–403
    [Google Scholar]
  63. Woodland D. L., Happ M. P., Gollob K. J., Palmer E. 1991; An endogenous retrovirus mediating deletion of alpha, beta T cells?. Nature, London 349:529–530
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-73-5-1087
Loading
/content/journal/jgv/10.1099/0022-1317-73-5-1087
Loading

Data & Media loading...

Most cited Most Cited RSS feed